PSEN1 and Alzheimer disease: Mutations that are established to be pathogenic in APP and PSEN1 were found in either a clinical DLB case [29]; or in pathologically confirmed DLB cases, of which 69% of the cohort also met pathological criteria for Alzheimer’s disease [27].